Product: The Altaseal®
AltaScience has developed AltaSeal® a female sterilisation device that can be implanted in awake patients using a small camera to view inside the uterus (hysterscopically) in a gynaecologist's office. It is easy to use, and will provide immediate sterilisation without the need for a post procedure confirmatory HSG (x-ray) before the device can be relied on as a contraceptive. Tubal ligation is the most widely used method of contraception worldwide and it accounts for c. 30% of US contraceptive usage. This is primarily due to its reliability and also the relative absence of chronic side effects associated with other methods of contraception.
AltaSeal® is placed in the fallopian tubes by a gynaecologist without the need for surgery. Once in place, AltaSeal® closes the fallopian tubes and prevents pregnancy. Unlike other devices on the market, AltaSeal® provides immediate closure of the tubes and there is no need to continue using other contraceptives nor is there a requirement for confirmatory procedures at a follow-up visit. AltaSeal® is a 300 series medical grade stainless steel implant (similar to coronary stents) with a series of specially designed laser cuts that determine its final shape after deployment. The product is currently in pilot clinical trials in Ireland and the results indicate that the implant can provide immediate occlusion of the fallopian tubes and is comfortable for women to have implanted. The Company works from a custom designed medical device development facility in Citywest, Dublin.
THIS DEVICE IS NOT FOR SALE IN THE UNITED STATES – IT IS AN INVESTIGATIONAL DEVICE LIMITED BY FEDERAL (OR UNITED STATES) LAW TO INVESTIGATIONAL USE.
AltaScience was founded in 2006 to develop a novel implantable medical device to be used as a new innovative method for female sterilisation. The company's founders, James Coleman, Christopher Cummins and Robert Perryman have extensive experience in the medical device industry and have been involved with several start-up ventures.